News

Protect your account in the Funding & Tenders Portal – Use two-factor authentication

Published on
| 3 years ago
Programmes
  • Horizon Europe
  • Digital Europe

The threats to cybersecurity increase continuously, affecting all systems managing data and information that might be interesting for intruders. The Funding & Tenders (F&T) Portal hosts a wealth of interesting information that might be under threat if users do not take the necessary measures.

Therefore the European Commission decided in Q4-2022 to increase the security and stimulate users to switch to using two-factor authentication (instead of the simple user name – password). A log-in as user is required in the F&T portal when you want to register as an organisation or to enter into the management of your proposal/project. 

This switch to two-factor authentication requires limited effort. You have to register a mobile device, app or USB security key and activate the two-factor authentication. At each login, you will then be prompted for your usual password and for a second factor that is sent to your phone, app or you'll have to enter your USB key. A short video guides you through the installation. There also is an FAQ page available.

Currently two-factor authorisation is used by less than 1% of the users, but it is a priority for the EC to increase the usage level. On a practical note: if you are planning on switching to a new phone in the near future (e.g. before summer), we would advise you to wait until then to activate the 2 factor authentication. In any other case, there is no reason to postpone the activation of the extra verification step. 

 

This is a revised version of a news item that was originally published on 2022-11-17.

Related news

myOverview

Sign up for personalised information

Stay informed about Horizon Europe, Digital Europe & EDF, filtered on what matters to you.

  • News in your domains
  • Event announcements
  • A personal dashboard
Sign up now

Only for stakeholders located in Flanders

Latest news

2049 articles available Browse all news
  • EIC

EIC Work Programme 2027 adopted

The 2027 work programme opens funding opportunities worth over €1.8 billion for strategic technologies and scaling up companies. The EIC work programme 2027 details the funding in six main schemes: EIC Pathfinder EIC Transition Advanced Innovation Challenges EIC Accelerator The EIC Strategic Technologies for Europe Platform (STEP) Scale Up EIC...

Read more
  • Defence
  • DIRS

Start2Def 2026 call open

The Start2Def 2026 selection process opened on 4 November 2026. Belgian startups and small SMEs can submit proof-of-concept ideas for one of two defence-related challenges.

Read more

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.